Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

On The Hill

May 5, 2017—Rep. Tom Marino (R-Pa.) May 3 released a statement regarding the withdrawal of his name for consideration for the Office of National Drug Control Policy (ONDCP) Director saying, “Due to a critical illness in my family, I have, with regret and the utmost respect, informed the White House that I must withdraw my name from consideration.” Press reports on April 11 announced that Rep. Marino was likely to be nominated as the next director of ONDCP.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org